CEO Message




President and Chief
Executive Officer

President and Chief Executive Officer Toshihiro Maeta
President and Chief Executive Officer Toshihiro Maeta

Healthcare business is now operating on a profitable basis.
The School DX business is also progressing smoothly.

Thank you very much for your continued support and kindness.


Our company group is focusing on the healthcare business and the school DX business, which are expected to contribute to the expansion of our performance, utilizing the cash cow of the content business to enhance our long-term corporate value. We aim to achieve profit expansion through the sales growth of both businesses.

Overview of financial results of Q1 FY2024

Increased profits. The healthcare business and the school DX business are progressing smoothly.

We have announced the financial results for the first quarter of the fiscal year ending September 2024.
The net sales decreased due to the impact of reduced revenue from video sales in the content business compared to the same period last year, but operating income increased. Particularly in the healthcare business, the introduction of cloud drug record service in pharmacies and the adoption of childcare DX service by municipalities have progressed well, resulting in increased sales and profits. In the school DX business, the expansion of the number of schools adopting the system during the new school term in April led to increased sales, and a significant reduction in losses was achieved due to decreased development costs, among other factors.


Consolidated business results (Period from October 1, 2023 to December 31, 2023)

Q1 FY2024

YoY
Millions of yen %

Net sales

6,625

(6.6)

Cost of sales

1,788

(29.6)

Gross profit

4,836

+6.2

SG&A

4,401

(4.6)

Operating income

435


(The previous year was (61) million yen)

Ordinary income

792


(The previous year was (88) million yen)

Profit attribute to owners of parent

630


(The previous year was (590) million yen)


Basic policy in FY2024

In the second quarter and beyond, we will continue to expand our cloud drug record service in the healthcare business and promote our platform strategy for childcare DX. Through these initiatives, we aim to achieve full-year profitability through further sales growth.

In the school DX business, we will seek to achieve continued sales growth and work towards achieving profitability in the second half of the year.

FY2024基本方針と重点課題

Image of medium-term profit (by segment)

Although upfront investments will continue for the time being, the school DX business is expected to achieve the fastest business growth, followed by the healthcare business, which we expect to maintain sustainable growth.

Over the medium and long terms, we believe that the healthcare business will be the driver of profit growth. By focusing on the steadily expanding cloud drug record service and the childcare DX service, we aim to achieve medium-term profit growth through growth in the subscription-based revenues of each service.

中期的な収益イメージ

We hope that we can continue to count on your support as we pursue our initiatives.


February, 2024